These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3765563)

  • 1. [Use of a microfiltration method in producing inactivated influenza vaccine].
    Ivanov NB; Zhemkov VP; Gromov VI; Cherkasov AN; Shashkov LA
    Vopr Virusol; 1986; 31(4):404-9. PubMed ID: 3765563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obtaining a lyophilized preparation of inactivated influenza vaccine].
    Goriunova VV; Bichurina MA; Gerasimov VA
    Tr Inst Im Pastera; 1979; 52():110-4. PubMed ID: 550533
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation].
    Polianskaia NIu
    Tr Inst Im Pastera; 1979; 52():107-10. PubMed ID: 550532
    [No Abstract]   [Full Text] [Related]  

  • 4. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
    Rudenko L; Isakova-Sivak I
    Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccines: from whole virus preparations to recombinant protein technology.
    Huber VC
    Expert Rev Vaccines; 2014 Jan; 13(1):31-42. PubMed ID: 24192014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a study of the technology of preparing inactivated chromatographic influenza vaccine].
    Peĭsel' SG; Nifontova AI; Bokhnevich GN; Zakharenko IV; Ermolaev AI
    Tr Inst Im Pastera; 1982; 59():65-6. PubMed ID: 7187570
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivated chromatographic influenza vaccine.
    Peradze T; Friedman E; Bitchurina M
    Med Biol; 1981 Feb; 59(1):41-6. PubMed ID: 7266085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increase in the specific activity of killed influenza vaccines by using polyene antibiotics].
    Shneĭder MA; Shtil'bans EB; Paleĭ EI; Vil'ner LM; Tereshin IM
    Antibiotiki; 1981 Jul; 26(7):532-7. PubMed ID: 7271267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allergenic action of inactivated influenza vaccines].
    Shpiliuk GF; Ten'kova TV; Subbotina TI; Shapiro NI
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):102-5. PubMed ID: 3751403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines].
    Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS
    Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].
    Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE
    Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
    Garmashova LM; Polezhaev FI; Aleksandrova GI
    Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
    Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live-attenuated vaccine candidate in the mouse model.
    Liu B; Hossain MJ; Mori I; Kimura Y
    J Med Virol; 2008 May; 80(5):888-94. PubMed ID: 18360902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Method of influenza virus UV inactivation applied to the manufacture of an inactivated chromatographic influenza vaccine].
    Zheleznova NV
    Tr Inst Im Pastera; 1982; 59():81-8. PubMed ID: 7187573
    [No Abstract]   [Full Text] [Related]  

  • 17. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets.
    Huber VC; McCullers JA
    J Infect Dis; 2006 Mar; 193(5):677-84. PubMed ID: 16453263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of a zonal purified influenza vaccine Gripax.
    Levy R; Zakay-Rones Z
    J Med Virol; 1982; 10(4):265-72. PubMed ID: 7161597
    [No Abstract]   [Full Text] [Related]  

  • 19. [Properties and biological activity of inactivated influenza vaccine].
    D'iachenko AP
    Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57].
    Aleksandrova GI; Medvedeva TE; Polezhaev FI; Garmashova LM; Budilovskiĭ GN
    Vopr Virusol; 1986; 31(4):411-4. PubMed ID: 2945324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.